Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ALK-Abello's 2013 sales performance.

IPA Best of Health Awards results announced

Epipen . ALK Abello. Langland . Healthcare professionals,  press campaign  . Targets . Crestor .

Hay fever study

ALK-Abelló's Grazax is the first allergy immunotherapy treatment available in tablet form.

PMEA 2006: Results

The success of the night continued with ALK-Abello's win of the Patient Focus Award for anaphalaxis treatment, Epipen. ... Peder Andersen, managing director of ALK-Abello, said of his company's success, Winning this award has been a fantastic reward for

Deals in development

Schering-Plough's other late stage acquisitions included Alk-Abello's allergy immunotherapies such as Grazax ó a grass pollen allergy vaccine tablet for which a series of European launches started

R&D costs push up ALK Abello's Q2 FY07 pre-tax losses

Danish pharmaceutical company ALK Abello has posted a Q2 FY07 pre-tax loss of DKK 29m (USD 5.3m), an increase on a Q2 FY06 loss of DMK 24m, due to ... ALK Abello said its year-on-year increase in costs for sales, marketing and administration was related

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Language barriers: Obesity has become a loaded word
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....